Association of lipoprotein(a) with the angiographic extent of coronary artery disease and selected angiographic findings in patients with acute coronary syndromes
Michał Miszczak, Beata Mokrauz, Paweł Piwowarczyk, Grzegorz Sobieszek, Michał Woś, Aleksander Prejbisz, Piotr Dobrowolski
{"title":"Association of lipoprotein(a) with the angiographic extent of coronary artery disease and selected angiographic findings in patients with acute coronary syndromes","authors":"Michał Miszczak, Beata Mokrauz, Paweł Piwowarczyk, Grzegorz Sobieszek, Michał Woś, Aleksander Prejbisz, Piotr Dobrowolski","doi":"10.1016/j.athplu.2026.100605","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The aim of this study was to investigate the association of serum lipoprotein(a) [Lp(a)] concentrations with the angiographic extent of coronary artery disease and selected angiographic findings in patients hospitalized with acute coronary syndromes (ACS).</div></div><div><h3>Methods</h3><div>This retrospective, single-center study included 1009 consecutive patients hospitalized with ACS, including unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI), between November 2022 and February 2025. Serum Lp(a) concentrations were measured routinely within the first 24 h of hospitalization. Associations between Lp(a) concentrations and angiographic findings were evaluated using multivariable logistic regression adjusted for major cardiovascular risk factors.</div></div><div><h3>Results</h3><div>The median Lp(a) concentration was 23.8 nmol/L, and elevated Lp(a) concentrations (≥105 nmol/L) were observed in 24.9% of patients. Higher Lp(a) concentrations were associated with a greater angiographic extent of coronary artery disease, including an increased prevalence of three-vessel disease and chronic total occlusions (CTO). In multivariable analyses, each 50 nmol/L increase in Lp(a) was associated with higher odds of three-vessel disease (OR 1.16, 95% CI 1.08–1.24; <em>p</em> < 0.001) and CTO (OR 1.17, 95% CI 1.06–1.29; <em>p</em> = 0.003). Using the clinically recommended threshold of ≥105 nmol/L, elevated Lp(a) remained independently associated with three-vessel disease (OR 1.51, 95% CI 1.12–2.03; <em>p</em> = 0.008) and CTO (OR 1.84, 95% CI 1.17–2.90; <em>p</em> = 0.009). Patients with premature STEMI exhibited the highest Lp(a) concentrations among all ACS subgroups. Among routinely measured lipid parameters, Lp(a) demonstrated the highest discriminatory performance for identifying CTO, although the overall discriminatory ability was modest.</div></div><div><h3>Conclusions</h3><div>Elevated Lp(a) concentrations were independently associated with the angiographic extent of coronary artery disease in patients with acute coronary syndromes, including multivessel disease and chronic total occlusions. These findings demonstrate a cross-sectional association between a single Lp(a) measurement obtained during the index hospitalization and selected angiographic findings. Further prospective studies are required to confirm these associations and determine their clinical significance.</div></div>","PeriodicalId":72324,"journal":{"name":"Atherosclerosis plus","volume":"65 ","pages":"Article 100605"},"PeriodicalIF":3.4000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Atherosclerosis plus","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266708952600060X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The aim of this study was to investigate the association of serum lipoprotein(a) [Lp(a)] concentrations with the angiographic extent of coronary artery disease and selected angiographic findings in patients hospitalized with acute coronary syndromes (ACS).
Methods
This retrospective, single-center study included 1009 consecutive patients hospitalized with ACS, including unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI), between November 2022 and February 2025. Serum Lp(a) concentrations were measured routinely within the first 24 h of hospitalization. Associations between Lp(a) concentrations and angiographic findings were evaluated using multivariable logistic regression adjusted for major cardiovascular risk factors.
Results
The median Lp(a) concentration was 23.8 nmol/L, and elevated Lp(a) concentrations (≥105 nmol/L) were observed in 24.9% of patients. Higher Lp(a) concentrations were associated with a greater angiographic extent of coronary artery disease, including an increased prevalence of three-vessel disease and chronic total occlusions (CTO). In multivariable analyses, each 50 nmol/L increase in Lp(a) was associated with higher odds of three-vessel disease (OR 1.16, 95% CI 1.08–1.24; p < 0.001) and CTO (OR 1.17, 95% CI 1.06–1.29; p = 0.003). Using the clinically recommended threshold of ≥105 nmol/L, elevated Lp(a) remained independently associated with three-vessel disease (OR 1.51, 95% CI 1.12–2.03; p = 0.008) and CTO (OR 1.84, 95% CI 1.17–2.90; p = 0.009). Patients with premature STEMI exhibited the highest Lp(a) concentrations among all ACS subgroups. Among routinely measured lipid parameters, Lp(a) demonstrated the highest discriminatory performance for identifying CTO, although the overall discriminatory ability was modest.
Conclusions
Elevated Lp(a) concentrations were independently associated with the angiographic extent of coronary artery disease in patients with acute coronary syndromes, including multivessel disease and chronic total occlusions. These findings demonstrate a cross-sectional association between a single Lp(a) measurement obtained during the index hospitalization and selected angiographic findings. Further prospective studies are required to confirm these associations and determine their clinical significance.
本研究的目的是探讨急性冠脉综合征(ACS)住院患者血清脂蛋白(a) [Lp(a)]浓度与冠状动脉疾病的血管造影范围和部分血管造影结果的关系。方法本回顾性单中心研究纳入了1009例连续住院的ACS患者,包括不稳定型心绞痛(UA)、非st段抬高型心肌梗死(NSTEMI)和st段抬高型心肌梗死(STEMI),时间为2022年11月至2025年2月。血清Lp(a)浓度在住院后的前24小时 h内常规测定。采用多变量logistic回归对主要心血管危险因素进行校正,评估Lp(a)浓度与血管造影结果之间的关系。结果Lp(a)浓度中位数为23.8 nmol/L, 24.9%的患者Lp(a)浓度升高(≥105 nmol/L)。较高的Lp(a)浓度与冠状动脉疾病的更大血管造影范围相关,包括三支血管疾病和慢性全闭塞(CTO)的患病率增加。在多变量分析中,Lp(a)每增加50 nmol/L,三支血管疾病(OR 1.16, 95% CI 1.08-1.24; p <; 0.001)和CTO (OR 1.17, 95% CI 1.06-1.29; p = 0.003)的几率就会增加。使用临床推荐的阈值≥105 nmol/L,升高的Lp(a)仍然与三支血管疾病(OR 1.51, 95% CI 1.12-2.03; p = 0.008)和CTO (OR 1.84, 95% CI 1.17-2.90; p = 0.009)独立相关。在所有ACS亚组中,早发STEMI患者的Lp(a)浓度最高。在常规测量的脂质参数中,Lp(a)在识别CTO方面表现出最高的区分性能,尽管总体区分能力一般。结论Lp(a)浓度升高与急性冠状动脉综合征(包括多支血管疾病和慢性全闭塞)患者冠状动脉病变的血管造影范围独立相关。这些结果表明在指数住院期间获得的单个Lp(a)测量与选定的血管造影结果之间存在横断面关联。需要进一步的前瞻性研究来证实这些关联并确定其临床意义。